← Back to Patent Explorer
US5523208A Expired / Lapsed US ⏱️ 0.0 years remaining

Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks

Assignee: Chemclark Inc
•
Filing: 1994-11-30
•
Granted: 1996-06-04
•
Expires: 2014-11-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for scanning nucleotide or DNA sequence data banks to identify genetic regions or genes coding for biologically interacting proteins.

Inventors

  • 👤 Heinz Kohler
  • 👤 J. Edwin Blalock

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 16:21
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; Y; Y10; Y10T; Y10T436/00; Y10T436/14; Y10T436/142222; Y10T436/143333

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 139 words
A method for determining the biological interaction of a nucleotide sequence of unknown biological interaction with inverse hydropathy to at least a portion of an amino acid sequence with a known function and biological interaction in a genetic data base, comprising the steps of: (a) obtaining a nucleotide sequence of unknown biological interaction; (b) translating the nucleotide sequence of unknown interaction to an amino acid sequence; (c) translating the genetic data base of nucleotide sequences of known biological interaction to amino acid sequences; (d) determining hydropathy of sequence of step (b) (e) determining hydropathy of sequences of step (c) (f) comparing result of step (d) with result of step (e) for regions of inverse hydropathy; (g) determining biological interaction of said nucleotide sequence of unknown biological interaction based upon inverse hydropathy with the nucleotide sequence of known biological interaction.
Claim 2
Independent Claim 139 words
A method for determining the biological interaction of a nucleotide sequence of unknown biological interaction with inverse hydropathy to at least a portion of an amino acid sequence with a known function and biological interaction in a genetic data base, comprising the steps of: (a) obtaining a nucleotide sequence of unknown biological interaction; (b) translating the nucleotide sequence of unknown interaction to an amino acid sequence; (c) translating the genetic data base of nucleotide sequences of known biological interaction to amino acid sequences; (d) determining hydropathy of sequence of step (b) (e) determining hydropathy of sequences of step (c) (f) comparing result of step (d) with result of step (e) for regions of inverse hydropathy; (g) determining biological interaction of said nucleotide sequence of unknown biological interaction based upon inverse hydropathy with the nucleotide sequence of known biological interaction.
Claim 3
Independent Claim 138 words
A method for determining the biological interaction of an amino acid sequence of a polypeptide with inverse hydropathy to at least a portion of an amino acid sequence of known function and biological interaction in a genetic data base comprising the steps of: (a) obtaining a nucleotide sequence of known biological interaction; (b) translating nucleotide sequence of known biological interaction to an amino acid sequence; (c) translating genetic data base of nucleotide sequences of unknown biological interaction to amino acid sequences; (d) determining hydropathy of sequence of step (b) (e) determining hydropathy of sequence of step (c) (f) comparing result of step (d) with result of step (e) for regions of inverse hydropathy; (g) determining the biological interaction of said amino acid sequence of a polypeptide based upon inverse hydropathy with the amino acid sequence of step (b).
Claim 4
Independent Claim 138 words
A method for determining the biological interaction of an amino acid sequence of a polypeptide with inverse hydropathy to at least a portion of an amino acid sequence of known function and biological interaction in a genetic data base comprising the steps of: (a) obtaining a nucleotide sequence of known biological interaction; (b) translating nucleotide sequence of known biological interaction to an amino acid sequence; (c) translating genetic data base of nucleotide sequences of unknown biological interaction to amino acid sequences; (d) determining hydropathy of sequence of step (b) (e) determining hydropathy of sequence of step (c) (f) comparing result of step (d) with result of step (e) for regions of inverse hydropathy; (g) determining the biological interaction of said amino acid sequence of a polypeptide based upon inverse hydropathy with the amino acid sequence of step (b).
Claim 5
Dependent Claim 16 words
A method according to claim 1, wherein said nucleotide sequence of known biological interaction is DNA.
Claim 6
Dependent Claim 16 words
A method according to claim 1, wherein said nucleotide sequence of known biological interaction is mRNA.
Claim 7
Dependent Claim 22 words
A method according to claim 1 wherein the nucleotide sequence of unknown biological interaction is read in the 5' to 3' direction.
Claim 8
Dependent Claim 22 words
A method according to claim 1 wherein the nucleotide sequence of unknown biological interaction is read in the 3' to 5' direction.
Claim 9
Dependent Claim 21 words
A method according to claim 1 wherein the nucleotide sequence of known biological interaction is an amino acid coding nucleotide sequence.
Claim 10
Dependent Claim 23 words
A method according to claim 1 wherein the nucleotide sequence of known biological interaction is a non-coding strand of a double stranded DNA.
Claim 11
Dependent Claim 36 words
A method according to claim 1 wherein the nucleotide sequence of biologically interacting function encodes a protein involved in a biological interaction selected from the group consisting of enzymatic cascade, signal pathway and receptor-ligand biological interaction.
Claim 12
Independent Claim 157 words
A method for determining the biological interaction of a nucleotide sequence of unknown biological interaction wherein said biological interaction is selected from the group consisting of enzymatic cascade, signal pathway and receptor-ligand biological interaction, with inverse hydropathy to at least a portion of a nucleotide sequence with a known function and biological interaction in a genetic data base, comprising the steps of: (a) obtaining a nucleotide sequence of unknown biological interaction; (b) determining the hydropathy of the second position of each triplet codon of the nucleotide sequence of unknown biological interaction; (c) determining the hydropathy of the second position of each triplet codon of a nucleotide sequence in genetic data base of nucleotide sequences of known biological interaction; (d) comparing result of step (b) with result of step (c) for regions of inverse hydropathy; (e) determining biological interaction of nucleotide sequence of unknown biological interaction based upon inverse hydropathy with the nucleotide sequence of known biological interaction.
Claim 13
Independent Claim 157 words
A method for determining the biological interaction of a nucleotide sequence of unknown biological interaction wherein said biological interaction is selected from the group consisting of enzymatic cascade, signal pathway and receptor-ligand biological interaction, with inverse hydropathy to at least a portion of a nucleotide sequence with a known function and biological interaction in a genetic data base, comprising the steps of: (a) obtaining a nucleotide sequence of unknown biological interaction; (b) determining the hydropathy of the second position of each triplet codon of the nucleotide sequence of unknown biological interaction; (c) determining the hydropathy of the second position of each triplet codon of a nucleotide sequence in genetic data base of nucleotide sequences of known biological interaction; (d) comparing result of step (b) with result of step (c) for regions of inverse hydropathy; (e) determining biological interaction of nucleotide sequence of unknown biological interaction based upon inverse hydropathy with the nucleotide sequence of known biological interaction.
Claim 14
Independent Claim 138 words
A method for determining the biological interaction of a nucleotide sequence of known function and biological interaction with inverse hydropathy to at least a portion of a nucleotide sequence with a unknown biological interaction in a genetic data base, comprising the steps of: (a) obtaining a nucleotide sequence of known biological interaction; (b) determining the hydropathy of the second position of each triplet codon of the nucleotide sequence of known biological interaction; (c) determining the hydropathy of the second position of each triplet codon of a nucleotide sequence in genetic data base of nucleotide sequences of unknown biological interaction; (d) comparing result of step (b) with result of step (c) for regions of inverse hydropathy; (e) determining biological interaction of nucleotide sequence of unknown biological interaction based upon inverse hydropathy with the nucleotide sequence of known biological interaction.
Claim 15
Independent Claim 138 words
A method for determining the biological interaction of a nucleotide sequence of known function and biological interaction with inverse hydropathy to at least a portion of a nucleotide sequence with a unknown biological interaction in a genetic data base, comprising the steps of: (a) obtaining a nucleotide sequence of known biological interaction; (b) determining the hydropathy of the second position of each triplet codon of the nucleotide sequence of known biological interaction; (c) determining the hydropathy of the second position of each triplet codon of a nucleotide sequence in genetic data base of nucleotide sequences of unknown biological interaction; (d) comparing result of step (b) with result of step (c) for regions of inverse hydropathy; (e) determining biological interaction of nucleotide sequence of unknown biological interaction based upon inverse hydropathy with the nucleotide sequence of known biological interaction.
Claim 16
Dependent Claim 49 words
The method of claim 1, further comprising the step of confirming the biological interaction of the nucleotide sequence of unknown biological interaction by testing the activity of the nucleotide sequence of unknown biological interaction and comparing test results with known activity of the nucleotide sequence of known biological interaction.
Claim 17
Dependent Claim 20 words
The method of claim 1, wherein said nucleotide sequence of unknown biological interaction is isolated from a sample and sequenced.

References Cited (Backward Citations)

US4963477A Cited
US4675283A Cited
US4820630A Cited
US5242794A Cited
US4863857A Cited
US5077195A Cited
US4925785A Cited
US5190856A Cited
US4921952A Cited
US5208144A Cited
US5081584A Cited
EP0411503A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-06-04 1999-12-04 2000-06-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-06-04 2003-12-04 2004-06-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-06-04 2007-12-04 2008-06-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag